For people whose weight, blood pressure, appetite, blood tests, medication list, or symptoms need proper interpretation — not another instruction to eat better and move more.
The gap most clinics miss: lifestyle advice without medication awareness is incomplete. Deprescribing without a replacement physiology is reckless. The proper consultation sits between the two — identifying the drivers beneath the signal, changing physiology safely, and deciding what should happen next with every medication involved.
Clinical appointments via CQC-registered Sutton Medical Consulting · Video consultations available UK-wide
Lifestyle medicine is an evidence-based clinical discipline that addresses the root causes of chronic disease. It works through six domains: nutrition, physical activity, sleep, mental wellbeing, healthy relationships, and minimising harmful substances — including, where appropriate, unnecessary medication.
The British Society of Lifestyle Medicine (BSLM) is the UK's professional body for the field. Its framework is used by credentialled physicians, GPs, and allied health professionals across the NHS and private sector.
What separates physician-led lifestyle medicine from general wellness advice is clinical accountability. A doctor can review your medications in light of lifestyle improvements, order bloods to measure change, and make a defensible case for deprescribing where the evidence supports it. A health coach cannot.
This practice combines the lifestyle medicine framework with a clinical specialism in deprescribing — the systematic, evidence-based reduction of medications that are no longer appropriate, no longer necessary, or are actively causing harm.
Learn about deprescribing →Whole food, predominantly plant-rich dietary patterns. Clinically linked to reversal of type 2 diabetes, improved lipid profiles, and reduced cardiovascular risk.
Structured and incidental movement. Strength training is particularly important for metabolic health, insulin sensitivity, and lean mass protection after GLP-1 treatment.
Restorative sleep quality and duration. Poor sleep drives insulin resistance, appetite dysregulation, and elevated cardiovascular risk independent of diet and exercise.
Stress reduction, emotional health, and psychological safety. Chronic stress activates the HPA axis, driving cortisol patterns that worsen metabolic and cardiovascular markers.
Social connection and support. Loneliness is a significant independent risk factor for cardiovascular disease, depression, and all-cause mortality.
This includes alcohol, tobacco — and, critically, unnecessary medication. Polypharmacy is one of the most underaddressed harms in UK primary care. Lifestyle medicine is incomplete without deprescribing.
The lifestyle medicine field in the UK includes a wide range of practitioners — from coaches and nutritionists to pharmacists and physiotherapists. This is appropriate. The six pillars do not require a medical degree to be taught.
But there is one thing only a doctor can do: review your medications in the light of improved metabolic health, make a clinical case for deprescribing, and take responsibility for the decision.
If you have improved your blood pressure through diet, exercise, and sleep — and your numbers now suggest you may not need antihypertensive medication — a coach can celebrate that with you. Only a physician can act on it clinically.
This practice is built around that junction: lifestyle medicine as the clinical foundation, deprescribing as the downstream outcome.
About Dr Dan Reardon →| What you need | Health coach | Lifestyle medicine physician |
|---|---|---|
| Dietary advice and support | ✓ | ✓ |
| Exercise and sleep guidance | ✓ | ✓ |
| Blood test interpretation | ✗ | ✓ |
| Medication review | ✗ | ✓ |
| Deprescribing where appropriate | ✗ | ✓ |
| GMC-registered and accountable | ✗ | ✓ |
| Clinical correspondence to GP | ✗ | ✓ |
| Written clinical plan | ✗ | ✓ |
These are the conditions where the evidence for lifestyle intervention is strongest — and where a clinician can make the case for reducing or stopping medication once lifestyle factors are addressed.
The evidence for dietary and lifestyle-driven remission of type 2 diabetes is now robust. When HbA1c normalises, there is a clinical case for reviewing metformin and other glucose-lowering agents.
Read: Pre-diabetes →Blood pressure responds substantially to dietary sodium reduction, weight loss, alcohol reduction, and aerobic exercise. Patients with well-controlled readings may be candidates for a stepdown review.
Read: High Blood Pressure →GLP-1 medications are highly effective — but most patients need a structured plan for what comes after. Appetite return and weight regain are predictable without a clinical transition framework.
View GLP-1 Exit Strategy →Statins are appropriate for many patients with elevated cardiovascular risk. But not all. A lifestyle-focused risk reassessment — including dietary change, weight, smoking, and exercise — may change the calculation.
Read: Statin review →Lifestyle factors — sleep, exercise, diet, social connection — have a significant evidence base for mental health. For patients stable on SSRIs who want to explore a cautious taper, this requires clinical support.
Read: SSRI deprescribing →PPIs are among the most over-prescribed drugs in the UK. Many patients on long-term proton pump inhibitors have never been reviewed for discontinuation. Lifestyle and dietary modification can often allow safe step-down.
Read: PPI review →On four or more medications? Many prescriptions accumulate over years without a coordinated review. One coherent clinician-led plan — with every drug assessed for current appropriateness — is the most important lifestyle medicine intervention available.
View Independent Medication Review →For patients with private health data — Medichecks, CGM, wearables — and no qualified interpretation. A metabolic audit with a goal-aligned written report for high-performance and longevity-focused patients.
View Metabolic Health service →Perimenopause and menopause have significant metabolic implications. Sleep, body composition, insulin sensitivity, and cardiovascular risk all shift. A clinician-led review puts the full picture together.
Read: Women's HRT →Four services. Each designed for a distinct clinical need. All physician-led, GMC-registered, and delivered via CQC-registered Sutton Medical Consulting.
Mounjaro · Wegovy · Ozempic
Clinician-led plan for tapering or stopping GLP-1 medication. Covers appetite return, muscle loss, weight regain risk, monitoring strategy, and a written exit plan. The lifestyle medicine work starts here — before stopping, not after.
From £495 · 60-minute review · Video available UK-wide
View service →SSRIs · PPIs · Statins · Blood pressure · Polypharmacy
Medication review and stepwise deprescribing plans built around your risk profile. The clinical endpoint of lifestyle medicine — where improved health justifies reducing the medication it was prescribed to manage.
From £395 · 60-minute review
View service →Comprehensive audit · Written report · Longevity focus
Comprehensive metabolic audit — bloods, markers, body composition, wearable data — with a goal-aligned written report. For high-performance and longevity patients who want everything assessed properly.
From £395 · 60-minute review
View service →For patients and families
A comprehensive independent clinical assessment of a patient's full medication history. Every drug reviewed for current appropriateness, interactions, and whether the original indication still applies. Delivered as a structured written report. Can be initiated by a family member.
£1,200 · Fixed fee · Two appointments + written report
View service →I continue to work in NHS A&E. That is not a credential footnote — it is the foundation of everything I do in private practice. Frontline emergency medicine gives you a precise understanding of what happens when chronic disease is poorly managed, and what it looks like when medication management goes seriously wrong.
Lifestyle medicine matters to me because I see the consequences of ignoring it every shift. Patients in their fifties and sixties with preventable conditions, on multiple medications with no coherent plan, whose quality of life has deteriorated in ways that systematic lifestyle intervention could have avoided.
I am completing the BSLM diploma to formalise what has been my clinical orientation for two decades — and to sit within the professional body that is building the evidence base and standards for this discipline in the UK.
My specialism within lifestyle medicine is deprescribing: the systematic review and safe reduction of medications that are no longer appropriate in light of lifestyle improvement, or that were prescribed without adequate justification in the first place. This is the part of lifestyle medicine that almost nobody does properly.
New York Times · Scientific American · GQ · Daily Telegraph · NBC The Doctors · BBC Radio London · LA Times · BuzzFeed · ABC News
"Lifestyle medicine tells you what to change. Deprescribing is what happens when you do — when the medications prescribed to manage your old biology need to be reviewed in light of your new one."
— Dr Dan Reardon · GMC 6098984For GPs & Referring Clinicians
This practice works alongside NHS colleagues. A written report with structured recommendations is provided after every review. Complex polypharmacy cases and GLP-1 exit strategy referrals welcome.
Information for GPs →Trusted By
"Long before 'lifestyle medicine' had a name, he was championing longevity with a muscle-first approach we now know is essential."
Andi Peters
British TV presenter and producer
Clinical articles on the conditions lifestyle medicine addresses — and the trials that underpin the approach.
Appetite return, weight trajectory, and the clinical plan for stopping semaglutide safely.
Read article →Week-by-week guide to stopping tirzepatide — what happens, what to watch for, and what to have in place first.
Read article →A clinical guide to distinguishing discontinuation symptoms from returning depression — the most important question in SSRI tapering.
Read article →What genetics, dose, drug choice, and duration actually explain about variable response to semaglutide and tirzepatide.
Read article →The landmark trial that quantified weight regain after stopping Wegovy. What it found, and what it means for your exit plan.
Read article →The tirzepatide equivalent of STEP 4. What the data shows about maintenance dosing, discontinuation, and long-term outcomes.
Read article →The questions most patients have before booking a consultation.
Physician-led. Evidence-based. A written clinical plan you leave with. Available in Sutton Coldfield or by video across the UK.
Clinical appointments via CQC-registered Sutton Medical Consulting · Sutton Coldfield, West Midlands